Library
PubMed Central Open Access
research article
Professional
Open access

Collagen implantgluteus maximus flap for perineal closure after extended abdominoperineal excision: NEAPE randomized clinical trial

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

BJS OpenLast synced 6/26/2026Status: syncedPMID: 42341212 pmidDOI: 10.1093/bjsopen/zrag079

Abstract Background Optimal reconstruction of the perineal defect after extended abdominoperineal excision remains uncertain, and randomized comparisons between biological mesh and myocutaneous flaps are lacking. This trial assessed whether an acellular porcine collagen implant (APCI) is non-inferior to a gluteus maximus myocutaneous flap (GMF) for pelvic floor reconstruction. s1 Methods NEAPE was a multicentre, randomized, non-inferiority trial conducted in eight Nordic referral centres. Adults undergoing extended abdominoperineal excision for rectal cancer were randomized to reconstruction with an APCI or unilateral GMF. The primary outcome was the proportion of patients underperforming in the timed-stands test at 6 months, defined relative to age- and sex-matched reference values. The non-inferiority margin was −10%. s2 Results Eighty-three patients were included in the modified intention-to-treat population (mean(standard deviation) age 68(10) years; 31% female). At 6 months, 71% of patients (25 of 35) in the implant group and 60% of patients (20 of 33) in the flap group underperformed. The risk difference was −11% (one-sided 95% confidence interval −30% to ∞), and non-inferiority was not demonstrated. s3 Conclusion The APCI did not demonstrate non-inferiority compared with the GMF. The direction of the effect favoured the flap, with results compatible with worse functional outcomes in the implant group. s4 Registration number . s5 This randomized multicentre clinical tri

Abstract

Abstract Background Optimal reconstruction of the perineal defect after extended abdominoperineal excision remains uncertain, and randomized comparisons between biological mesh and myocutaneous flaps are lacking. This trial assessed whether an acellular porcine collagen implant (APCI) is non-inferior to a gluteus maximus myocutaneous flap (GMF) for pelvic floor reconstruction. s1 Methods NEAPE was a multicentre, randomized, non-inferiority trial conducted in eight Nordic referral centres. Adults undergoing extended abdominoperineal excision for rectal cancer were randomized to reconstruction with an APCI or unilateral GMF. The primary outcome was the proportion of patients underperforming in the timed-stands test at 6 months, defined relative to age- and sex-matched reference values. The non-inferiority margin was −10%. s2 Results Eighty-three patients were included in the modified intention-to-treat population (mean(standard deviation) age 68(10) years; 31% female). At 6 months, 71% of patients (25 of 35) in the implant group and 60% of patients (20 of 33) in the flap group underperformed. The risk difference was −11% (one-sided 95% confidence interval −30% to ∞), and non-inferiority was not demonstrated. s3 Conclusion The APCI did not demonstrate non-inferiority compared with the GMF. The direction of the effect favoured the flap, with results compatible with worse functional outcomes in the implant group. s4 Registration number . s5 This randomized multicentre clinical trial investigated whether an acellular porcine collagen implant result in less functional problems than a gluteus maximus myocutaneous flap for the reconstruction of the pelvic floor after an extended abdominoperineal resection. Comparing the postoperative physical performance of 85 patients with rectal cancer, non-inferiority of the acellular porcine collagen implant could not be demonstrated. teaser

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.